Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
Ansa Biotechnologies provides DNA synthesis capabilities, enabling direct synthesis up to 50 kb without assembly or cloning, powered by proprietary enzymatic technology. It also enables no-assembly direct synthesis for up to 600 bp of complex sequences that other vendors find difficult to synthesize. The company offers a catalog of cloning, bacterial, mammalian, AAV, and transcription vectors and DNA fragments, with custom vectors available in Early Access, serving healthcare, pharmaceuticals, and biological research with fast timelines and competitive pricing.
Parse Score
#11 of 61 in Precision Fermentation Alternative Protein Services
Sources
ansabio.com shapes more of what AI says about Ansa Biotechnologies than any other source, at 62% of its citations.
genesynthesisscreening.centerforhealthsecurity.org · reddit.com · seqanswers.com · startus-insights.com
The market map
Precision Fermentation Alternative Protein Services →Where AI ranks Ansa Biotechnologies